The story of Viagra, and its creator copyright, presents a challenging case study for investors. Initially a blockbuster drug, generating billions in sales , its intellectual property lapse created a wave of generic competition , significantly eroding its dominance. While some firms may attempt to capitalize on male sexual dysfunction, the present